Literature DB >> 11224434

Perspectives on cognitive psychopharmacology research.

T. Duka1, H.V. Curran, J.M. Rusted, H.J. Weingartner.   

Abstract

This article discusses new perspectives in the psychopharmacology of cognition and analyses the advantages and disadvantages of using drugs as tools to study the mechanisms underlying memory functions. The use of 'stages' in the processing of information as a means for the analysis of cognitive operations is critically discussed as a rigid approach which can only partially accommodate different cognitive functions. Theoretical models of memory 'systems' and allocation of attentional resources are presented alongside findings from the two types of more commonly used drugs in cognitive psychopharmacology: the benzodiazepines (BZ) and the anticholinergics. In a post-hoc analysis of the effects of BZ and scopolamine on memory and attention, it has become clear that these newer theoretical models can accommodate most, but not all, of the effects of BZ and scopolamine on cognition. It is suggested that the development of cognitive tasks on the basis of these models and the execution of prospective studies with drugs as tools taking in to account the 'systems' approach to interpretation of data may be more useful for understanding cognitive functions.

Entities:  

Year:  1996        PMID: 11224434

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

1.  An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze.

Authors:  N Collinson; J R Atack; P Laughton; G R Dawson; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  2006-04-22       Impact factor: 4.530

2.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

3.  What makes lorazepam different from other benzodiazepines?

Authors:  S Pompéia; G M Manzano; S Tufik; O F A Bueno
Journal:  J Physiol       Date:  2005-12-01       Impact factor: 5.182

4.  Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.

Authors:  Leah Makaron; Casey A Moran; Ojas Namjoshi; Sundari Rallapalli; James M Cook; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

5.  Effects of the amnesic drug lorazepam on complete and partial information retrieval and monitoring accuracy.

Authors:  M Izaute; E Bacon
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

6.  Acute effects of triazolam on false recognition.

Authors:  M Z Mintzer; R R Griffiths
Journal:  Mem Cognit       Date:  2000-12

7.  Dose effects of triazolam and scopolamine on metamemory.

Authors:  Miriam Z Mintzer; Bethea A Kleykamp; Roland R Griffiths
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

8.  Dose effects of triazolam on brain activity during episodic memory encoding: a PET study.

Authors:  Miriam Z Mintzer; Hiroto Kuwabara; Mohab Alexander; James R Brasic; Weiguo Ye; Monique Ernst; Roland R Griffiths; Dean F Wong
Journal:  Psychopharmacology (Berl)       Date:  2006-07-18       Impact factor: 4.530

9.  The effect of alcohol and repetition at encoding on implicit and explicit false memories.

Authors:  S N Garfinkel; Z Dienes; T Duka
Journal:  Psychopharmacology (Berl)       Date:  2006-08-11       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.